As the NHS grapples with unprecedented demand, workforce pressures and growing elective backlogs, agentic automation is ...

Despite weight loss drugs' popularity, the “average” woman is still in the plus category, and they are finding their options ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...

The IRBs are there for primarily federally funded research. But because this AI research is done with unconsented human data, ...

HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025 ...

Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of Chemistry, Chinese Academy of Sciences, have ...

In 2023, the AI market in pharmaceuticals and biotech was valued at $1.8 billion, and it’s expected to grow to $13.1 billion ...

As language models (LMs) improve at tasks like image generation, trivia questions, and simple math, you might think that ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Scleroderma is a rare autoimmune disease involving an overproduction of the protein collagen. Linear scleroderma usually begins as a streak of hardened, waxy, discolored skin on the forehead, an arm, ...

First-line treatment selection in follicular lymphoma is closely tied to tumor stage, disease burden, and patient-specific ...

A CMS pilot program will require providers in six states to submit select Medicare services for AI-enabled prior authorization or post-service medical review.